<table border="1"><tr><th>regular name</th><td><ul><li>4- [6-amino-5-bromo-2-((4-vephenyl) amino] pyrimidin-4-y] Oxy-3,5-dimethylbenzonitrile</li></ul></td></tr><tr><th>Treats</th><td><ul><li>HIV infection</li></ul></td></tr><tr><th>Commercial Name</th><td><ul><li>Intelence</li></ul></td></tr><tr><th>Ashp | Drugs.com</th><td><ul><li>Effects</li></ul></td></tr><tr><th>Medialine Plus</th><td><ul><li>A608016</li></ul></td></tr><tr><th>Legal situation</th><td><ul><li>European Pharmaceutical Agency: Local, Food and Drug Administration: Locism</li></ul></td></tr><tr><th>Safety category during pregnancy</th><td><ul><li>B1 | (Australia) | B | (United States)</li></ul></td></tr><tr><th>Ways to give medicine</th><td><ul><li>oral</li></ul></td></tr><tr><th>Protein link</th><td><ul><li>99.9%</li></ul></td></tr><tr><th>metabolism (metabolism) medicine</th><td><ul><li>liver (cytokrome 3a4, CYP2C9 &amp; CYP2C19- MediaATED)</li></ul></td></tr><tr><th>Omar Al -Nasha Al -Biosa</th><td><ul><li>41 Â± 20 Hours</li></ul></td></tr><tr><th>Directed by (Selja)</th><td><ul><li>Faices (93.7%), URINE (1.2%)</li></ul></td></tr><tr><th>CAS</th><td><ul><li>269055-15-4</li></ul></td></tr><tr><th>KT</th><td><ul><li>j05j05ag04 ag04</li></ul></td></tr><tr><th>Bob Kim</th><td><ul><li>CID 193962</li></ul></td></tr><tr><th>Echa Infocard ID</th><td><ul><li>100.207.546</li></ul></td></tr><tr><th>Driving Bank</th><td><ul><li>db06414</li></ul></td></tr><tr><th>Kim Spider</th><td><ul><li>168313</li></ul></td></tr><tr><th>The unique component</th><td><ul><li>0C50HW4FO1</li></ul></td></tr><tr><th>Kyoto</th><td><ul><li>D04112</li></ul></td></tr><tr><th>Cheml</th><td><ul><li>Cheml308954</li></ul></td></tr><tr><th>Niaid Chemdb</th><td><ul><li>105156</li></ul></td></tr><tr><th>Protein Data Bank Ligand ID</th><td><ul><li>65B (PDBE, RCSB PDB)</li></ul></td></tr><tr><th>Chemical Format</th><td><ul><li>C | 20 | H | 15 | BR | N | 6 | o</li></ul></td></tr><tr><th>Molecular Bloc</th><td><ul><li>435.28 G/Mol</li></ul></td></tr></table>